Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03395080
Title A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Relapsed/ Refractory Endometrioid Endometrial or Endometrioid Ovarian Cancer (P204) (P204)
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Leap Therapeutics, Inc.
Indications

endometrioid ovary carcinoma

ovarian endometrial cancer

Therapies

DKN-01

DKN-01 + Paclitaxel

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.